Black Rock Inc. Biocryst Pharmaceuticals Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 19,956,255 shares of BCRX stock, worth $153 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,956,255

Previous 18,440,729 8.22%

Holding current value

$153 Million

Previous $93.7 Million 31.65%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.13 - $6.79 $6.26 Million - $10.3 Million	1,515,526 Added 8.22%	19,956,255 $123 Million
Q1 2024 May 10, 2024	SELL	$4.89 - $7.65 $1.18 Million - $1.84 Million	-240,641 Reduced 1.29%	18,440,729 $93.7 Million
Q4 2023 Feb 13, 2024	BUY	$4.98 - $6.77 $9.5 Million - $12.9 Million	1,907,066 Added 11.37%	18,681,370 $112 Million
Q3 2023 Nov 13, 2023	BUY	$6.71 - $7.92 $8.58 Million - $10.1 Million	1,278,601 Added 8.25%	16,774,304 $119 Million
Q2 2023 Aug 11, 2023	BUY	$6.96 - $8.81 $4.67 Million - $5.91 Million	670,905 Added 4.53%	15,495,703 $109 Million
Q1 2023 May 12, 2023	SELL	$7.94 - $11.84 $747,606 - $1.11 Million	-94,157 Reduced 0.63%	14,824,798 $124 Million
Q4 2022 Feb 13, 2023	BUY	$10.5 - $14.2 $12 Million - $16.2 Million	1,143,960 Added 8.3%	14,918,955 $171 Million
Q3 2022 Nov 14, 2022	SELL	$10.79 - $14.81 $2.29 Million - $3.15 Million	-212,423 Reduced 1.52%	13,774,995 $174 Million
Q2 2022 Aug 12, 2022	SELL	$7.89 - $17.88 $903,854 - $2.05 Million	-114,557 Reduced 0.81%	13,987,418 $148 Million
Q1 2022 May 12, 2022	SELL	$11.56 - $19.76 $7.92 Million - $13.5 Million	-685,420 Reduced 4.64%	14,101,975 $229 Million
Q4 2021 Feb 10, 2022	SELL	$11.18 - $15.46 $6.08 Million - $8.4 Million	-543,463 Reduced 3.54%	14,787,395 $205 Million
Q3 2021 Nov 09, 2021	SELL	$14.21 - $17.65 $2.14 Million - $2.66 Million	-150,469 Reduced 0.97%	15,330,858 $220 Million
Q2 2021 Aug 11, 2021	BUY	$9.5 - $17.24 $147 Million - $267 Million	15,481,327 New	15,481,327 $245 Million

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account